The Tullis team has completed portfolio company investments in the medical device, healthcare services and technology, specialty pharmaceuticals, and biotechnology sectors.
Where It Counts
Tullis funds’ investments in people, products, technologies, and services have a significant impact on global health. Here’s a snapshot of what our financial support has helped our portfolio companies achieve.
60+
Countries Using Products/Services
2.6K+
Employees
15M+
Patients Impacted
1.9K+
Patents Approved
Portfolio
Our team invests in medical devices, healthcare services and technology, specialty pharmaceuticals, and biotechnology, and has backed market leaders such as these current and exited portfolio companies.
Portfolio
Our team invests in medical devices, healthcare services and technology, specialty pharmaceuticals, and biotechnology, and has backed market leaders such as these current and exited portfolio companies.
News
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.